• 400+
    Pharmaceutical Partners
  • 150+
    Biomarker Assays
  • 300+
    Method Validations
  • 40+
    CDx

Clinical Testing

Patient Testing for Precision Medicine

  • Pan solid tumor
    Meet the diverse demands from clinicians and patients, MEDx Translational Medicine (MEDx) has developed a series of solid tumor tests, including pan-cancer gene panel tests, single cancer gene panel assays, and immunohistochemistry (IHC).
  • Hematologic Malignancy
    Most recently, molecular diagnostic products using PCR and next-generation sequencing (NGS) have significantly improved the understanding of molecular mechanism of hematological malignancies, leading to the right choice of molecular targeting drugs for precision therapy for the individual patients in clinic.
  • Infectious Disease
    Infectious Disease

About MEDx

Translational Medicine

MEDx Translational Medicine Co., Ltd (simply MEDx) was founded in 2013, formerly known as QIAGEN (Suzhou) Translational Medicine Co., Ltd.Obtained with comprehensive technology platforms, high quality system, and strong IVD R&D experience, MEDx has become a leading innovative company in companion diagnostics and the total solution provider for precision medicine in China.


Taking advantage of the comprehensive translational platforms including genomics, proteomics, cytomics, and pathology, MEDx offers integrated solutions from biomarker discovery, target validation, molecular testing, and patient  stratification for drug clinical trials, to the IVD/CDx R&D and commercialization. With a world-class technical team and a rich IVD/CDx pipeline, MEDx collaborates with hundreds of world-renowned pharmaceutical companies.

view more >>

Events

Dragon Boat Festival
Welcome to visit the MEDx Booth at Medlab Middle East 2024

Time:5-8 February, 2024Address:Dubai World Trade CentreMEDx Booth No: # Z2.H19We are honored

Meet MEDx at Medlab Middle East | Dubai 2024
On series |PIK3CA gene mutation and targeted therapy

Introduction The study of cancer has been extended from single genes to macrogenes, and from sing

MEDx and illumina jointly promote gene sequencing technology to help global new drug research

In the development process of innovative drugs, the accompanying diagnosis is like a indicating lamp

MEDx's Debut at 2023 Medlab Asia & Asia Health a Complete Success

From August 16 to 18, MEDx participated in the 2023 MedLab Asia held at the IMPACT Exhibition Centre

MEDx Partners with Junshi Biosciences in the Innovative Co-Development of Companion Diagnostics

On May 22, 2023, Shanghai Junshi Biosciences Co., Ltd. (hereinafter referred to as "Junshi Bios

HRD Panel of MEDx

Homologous Recombination Repair (HRR) and Poly ADP-ribose Polymerase (PARP) Repair are two important

Nano-Immunotherapy Delivers Checkpoint Inhibition And Anticancer Drug to Lung Tumors in Mice

Researchers at the Brigham and Women’s Hospital, a founding member of the Mass General Brigham heal

Checkpoint Therapy Could Be Enhanced by Cutting CD8+ T Cell/Treg Crosstalk

Mixed signals impair communications of all sorts—including communications between immune cells stru

Obesity Paradox of Cancer Immunotherapy Response Linked to Immune Checkpoint Protein on Macrophages

Immune system cells called macrophages play an unexpected role in the complicated connection between

Secondary Cancer Risk Is Low After CAR T Cell Treatment: Stanford Study

Despite warnings about the drug class from the FDA, a large study led by Stanford Medicine has found

Coherus, Junshi’s PD-1 Blocker Loqtorzi Aces Phase III Liver Cancer Trial

Junshi Biosciences and Coherus BioSciences on Wednesday unveiled data from the Phase III HEPATORCH s

Scientists discover how the physics of colon cancer cells contributes to metastasis

A study led by the Institute for Bioengineering of Catalonia (IBEC) has investigated how the mechani

Novel Antibody Treatment Shows Promise against Kidney Cancer

Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatmen

CAR T-Cell Therapy Gets Second Wind after Biomaterials Put Skin in the Game

CAR T cells—that is, T cells that have been taken from patients, engineered to express chimeric ant

Show of MEDx by CCTV